Breast cancer is a group of diseases in which cells in breast tissue change and divide uncontrollably, typically resulting in a lump or mass. Breast cancer can begin in different areas of the breast, such as the ducts, lobules, and the tissue in between.

Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. It is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies...

Solid tumors are an abnormal mass of tissue that usually does not contain cysts or liquid areas. These may be benign (not cancerous) or malignant (cancerous). Different types of solid tumors are named for the type of cells that form them. Examples of solid tumors are sarcomas, carcinomas, and lymphomas.

The human immunodeficiency virus (HIV) can lead to acquired immunodeficiency syndrome or AIDS if not treated. Unlike some other viruses, the human body can’t get rid of HIV completely, even with treatment. So once you get HIV, you have it for life...

Leukemia is a cancer of the early blood-forming cells; most often, it is of the white blood cells, but in some cases it starts in other blood cell types. There are several types of leukemia...

Our team had the exceptional opportunity to interview doctor Francisco Kerdel-Vegas, a renowned dermatologist, researcher, diplomat and professor born in Venezuela, currently residing in Spain. Worked with doctor Convit for more than 25 years on infectious diseases.

We are pleased to end this new year of efforts and achievements by sharing with you a brief review of our journey during the year.

In 1990, the Human Genome Project (HGP) began with the primary goal of identifying the 20,000-25,000 genes in human DNA. Although this effort ended in 2003, it is still widely regarded in the scientific community as a monumental feat of coordination and discovery. The resulting information from this 13 year effort has provided a conceptual and technological foundation for a shift in medicine in the near future. Although the project has ended, the challenge of harnessing and applying the information still continues today.

Jacinto Convit World Organization (JCWO) is pleased to announce the publication of their latest work “Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment” in Oncotarget.

Out of the five cancer immunotherapy types listed above, JCWO’s research and development is in the domain of cancer vaccines. This work in immunotherapy began decades ago when Dr. Jacinto Convit successfully developed and applied therapeutic vaccines for Leprosy and Cutaneous Leishmaniasis, the latter being widely used in Venezuela and other Latin-American countries.

Summary of 2018 achievements for the Jacinto Convit World Organization.

Since its inception, the Jacinto Convit World Organization has strived to help the most vulnerable, be useful to others and work for humanity, by continuing to develop a breast cancer immunotherapy (vaccine) designed by Dr. Jacinto Convit during the last years of his life.